877P Exploratory efficacy and translational results from the safety run in of AHEAD-MERIT, a phase II trial of first line pembrolizumab plus the fixed-antigen cancer vaccine BNT113 in advanced HPV16+ HNSCC
医学
彭布罗利珠单抗
癌症疫苗
肿瘤科
病毒学
癌症
内科学
免疫疗法
作者
Nabil F. Saba,K. Klinghammer,E. Castelluci,A.D. Colevas,T. Rutkowski,D. Thurner,U. Müller-Richter,Massimo Di Maïo,Jasmaninder Singh Grewal,C.H.H. Ottensmeier,J. Dias,Huyuan Yang,Rishub K. Das,J. Furlanetto,A-K. Herzfeldt,M-C. Kühnle,Alexander Ulges,J U Alles,Ö. Türeci,Uğur Şahin